Precision BioSciences, Inc. (DTIL)
7.80
-0.60
(-7.14%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
0.00 (0.00%)
After-Hours: 18:59
Precision BioSciences Market Cap : 206.18M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 222.04M |
| August 26, 2026 | 224.42M |
| August 25, 2026 | 226.01M |
| August 24, 2026 | 223.36M |
| August 21, 2026 | 233.94M |
| August 20, 2026 | 230.50M |
| August 19, 2026 | 224.69M |
| August 18, 2026 | 217.55M |
| August 17, 2026 | 195.61M |
| August 14, 2026 | 196.40M |
| August 13, 2026 | 192.97M |
| August 12, 2026 | 196.14M |
| August 11, 2026 | 198.52M |
| August 10, 2026 | 197.19M |
| August 07, 2026 | 197.99M |
| August 06, 2026 | 196.14M |
| August 05, 2026 | 197.46M |
| August 04, 2026 | 192.44M |
| August 03, 2026 | 182.19M |
| July 31, 2026 | 180.38M |
| July 30, 2026 | 180.64M |
| July 29, 2026 | 177.80M |
| July 28, 2026 | 185.03M |
| July 27, 2026 | 187.09M |
| July 24, 2026 | 188.12M |
| Date | Value |
|---|---|
| July 23, 2026 | 189.16M |
| July 22, 2026 | 188.90M |
| July 21, 2026 | 196.64M |
| July 20, 2026 | 189.93M |
| July 17, 2026 | 203.09M |
| July 16, 2026 | 214.71M |
| July 15, 2026 | 227.35M |
| July 14, 2026 | 221.41M |
| July 13, 2026 | 221.67M |
| July 10, 2026 | 226.06M |
| July 09, 2026 | 236.38M |
| July 08, 2026 | 239.48M |
| July 07, 2026 | 238.70M |
| July 06, 2026 | 212.64M |
| July 02, 2026 | 211.09M |
| July 01, 2026 | 203.35M |
| June 30, 2026 | 202.83M |
| June 29, 2026 | 204.38M |
| June 26, 2026 | 188.12M |
| June 25, 2026 | 174.19M |
| June 24, 2026 | 173.93M |
| June 23, 2026 | 179.35M |
| June 22, 2026 | 182.71M |
| June 18, 2026 | 175.74M |
| June 17, 2026 | 167.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 233.72B |
| 4D Molecular Therapeutics, Inc. | 809.99M |
| Agenus, Inc. | 326.86M |
| Anika Therapeutics, Inc. | 283.18M |
| BioCryst Pharmaceuticals, Inc. | 2.507B |
Market Cap Related Metrics
| PS Ratio | 3.527 |
| Price to Book Value | 4.552 |
| Price | 7.80 |
| Earnings Yield | -36.53% |